LOL quote, "Military demand is huge globally as well as 3rd World Countries. White Blood cell restoration following destructive cancer chemo. $OCAT's Blood Platelet program."
Well, all EXCEPT for the fact that their own, duly filed SEC 10-Q just indicated they're highly unlikely to even fund the so called "blood" whatever- as they're CASH LOW, desperately seeking financing, living off of Lincoln w/ $18 million left and about 9 months cash tops- and that's w/o paying ONE DIME yet of high cost, "new" clinical trials costs and thus they stated they are NOT LIKELY to "fund" any non-core programs other than the "eye" - as they need to pick their battles and spend their money where most applicable (will give full analysis of 10-K later when I get time, w/ pages numbers, analysis of statement of operations and balance sheet page, etc)
So, they don't have any magic "blood platelet" so called "program" let alone any attempts to get such a product approved by the FDA or anyone else.
Simply NOT TRUE per their own duly filed SEC 10-K, the most recent one, just released. I'm going with the 10-K as the source of FACTUAL INFORMATION. But hey, that's just me.
My 6.2 cents, pre R/S price worth
